Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
July 06 2022 - 4:30PM
Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical
technology company focused on elevating the standard of care by
driving the evolution of digital health, today announced that it
has granted restricted stock unit awards to one (1) employee, who
was not an executive officer, as an inducement for them to accept
employment with Surgalign, and representing the right to receive,
in the aggregate, up to 9,259 shares of Surgalign common stock. The
award was granted on July 1, 2022 and it was made under the
Surgalign Holdings, Inc. 2021 Inducement Plan. One-third of the
restricted stock units vest on the first anniversary of the date of
grant, and one-eighth of the remaining restricted stock units vest
on each subsequent quarterly anniversary of the date of grant, such
that the award will be fully vested on the third anniversary of the
date of grant, subject to continued employment through the
applicable vesting date.
The awards were approved by the independent Compensation
Committee of the Board of Directors of Surgalign Holdings and were
granted to the new employees as an inducement material to their
acceptance of employment with Surgalign pursuant to Nasdaq
rules.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company
committed to the promise of digital health and is building out its
digital surgery platform to drive transformation across the
surgical landscape. Uniquely aligned and resourced to advance the
standard of care, the company is building technologies surgeons
will look to for what is truly possible for their patients.
Surgalign is focused on bringing surgeons solutions that
predictably deliver superior clinical and economic outcomes.
Surgalign markets products throughout the United States and in more
than 50 countries worldwide through an expanding network of top
independent distributors. Surgalign is headquartered in Deerfield,
IL, with commercial, innovation and design centers in San Diego,
CA, Warsaw and Poznan, Poland and Wurmlingen, Germany. Learn more
at www.surgalign.com and connect on
LinkedIn and Twitter.
Forward Looking Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on management’s
current expectations, estimates and projections about our industry,
our management's beliefs and certain assumptions made by our
management. Words such as "anticipates," "expects," "intends,"
"plans," "believes," "seeks," "estimates," variations of such words
and similar expressions are intended to identify such
forward-looking statements. These statements are not guarantees of
future performance and are subject to risks and uncertainties,
including the risks described in public filings with the U.S.
Securities and Exchange Commission (SEC). Our actual results may
differ materially from the anticipated results reflected in these
forward-looking statements. Copies of the company's SEC filings may
be obtained by contacting the company or the SEC or by visiting
Surgalign's website at www.surgalign.com or the SEC's
website at www.sec.gov.
Investor and Media Contact:Glenn
WienerIR@surgalign.com+1 917 887 8434
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Apr 2023 to Apr 2024